login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
OCULAR THERAPEUTIX INC (OCUL) Stock News
NASDAQ:OCUL -
US67576A1007
-
Common Stock
12.3
USD
+0.17 (+1.4%)
Last: 8/22/2025, 8:00:02 PM
12.58
USD
+0.28 (+2.28%)
Pre-Market:
8/25/2025, 5:12:16 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
OCUL Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: Chartmill
OCULAR THERAPEUTIX INC (NASDAQ:OCUL) Reports Mixed Q2 2025 Earnings Amid Clinical Progress
19 days ago - By: The Motley Fool
- Mentions:
AMD
OCUL Sales Drop 18%
20 days ago - By: Zacks Investment Research
- Mentions:
PSTV
Ocular Therapeutix (OCUL) Reports Q2 Loss, Misses Revenue Estimates
20 days ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Reports Second Quarter 2025 Financial Results and Business Highlights
20 days ago - By: Benzinga
- Mentions:
AFG
CXDO
YUM
PACK
...
Earnings Scheduled For August 5, 2025
21 days ago - By: Benzinga
What's Next: Ocular Therapeutix's Earnings Preview
a month ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences
2 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company
2 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025
4 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights
4 months ago - By: Zacks Investment Research
- Mentions:
ESPR
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
4 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences
4 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025
5 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
5 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Participate in Two Investor Conferences in April
5 months ago - By: The Motley Fool
Why Ocular Therapeutix Was Bumping Higher This Week
6 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
6 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights
6 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2024 Results on March 3, 2025
7 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting
Please enable JavaScript to continue using this application.